tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O
Germany Market

OncoTherapy Science (30O) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
OncoTherapy Science, Inc.’s (30O) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting OncoTherapy Science, Inc. is a Sell.
OncoTherapy Science, Inc.’s (30O) 20-Day exponential moving average is 0.09, while OncoTherapy Science, Inc.’s (30O) share price is €0.11, making it a Buy.
OncoTherapy Science, Inc.’s (30O) 50-Day exponential moving average is 0.10, while OncoTherapy Science, Inc.’s (30O) share price is €0.11, making it a Buy.

OncoTherapy Science (30O) Pivot Points

Jan 12, 2026, 05:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.10
0.10
0.10
0.10
0.10
0.10
0.10
Fibonacci
0.10
0.10
0.10
0.10
0.10
0.10
0.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoTherapy Science (30O) Moving Averages

Jan 12, 2026, 05:14 PM
Period
Simple
Exponential
MA5
0.10Buy
0.10Buy
MA10
0.09Buy
0.09Buy
MA20
0.09Buy
0.09Buy
MA50
0.09Buy
0.10Buy
MA100
0.11Sell
0.11Buy
MA200
0.12Sell
0.12Sell
OncoTherapy Science, Inc.’s (30O) 10-Day exponential moving average is 0.09, while OncoTherapy Science, Inc.’s (30O) share price is €0.11, making it a Buy.
OncoTherapy Science, Inc.’s (30O) 100-Day exponential moving average is 0.11, while OncoTherapy Science, Inc.’s (30O) share price is €0.11, making it a Buy.
OncoTherapy Science, Inc.’s (30O) stock price is €0.11 and OncoTherapy Science, Inc.’s (30O) 50-day simple moving average is 0.09, creating a Buy signal.
OncoTherapy Science, Inc.’s (30O) stock price is €0.11 and OncoTherapy Science, Inc.’s (30O) 100-day simple moving average is 0.11, creating a Sell signal.
OncoTherapy Science, Inc.’s (30O) stock price is €0.11 and OncoTherapy Science, Inc.’s (30O) 200-day simple moving average is 0.12, creating a Sell signal.

OncoTherapy Science (30O) Technical Indicators

Jan 12, 2026, 05:14 PM
Name
Value
Implied Action
RSI (14)
68.77
Neutral
STOCH (9,6)
30.36
Neutral
STOCHRSI (14)
30.36
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
29.45
Neutral
Williams %R
-51.79
Buy
CCI (14)
197.00
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
34.73
Neutral
ROC
22.22
Buy
OncoTherapy Science, Inc.’s (30O) Relative Strength Index (RSI) is 68.77, creating a Neutral signal.
OncoTherapy Science, Inc.’s (30O) Trend Strength Indicator (ADX) is 29.45, creating a Neutral signal.
OncoTherapy Science, Inc.’s (30O) Commodity Channel Index (CCI) is 197.00, creating a Sell signal.
OncoTherapy Science, Inc.’s (30O) Price Rate of Change (ROC) is 22.22, creating a Buy signal.

FAQ

Is 30O a Buy, Hold, or Sell?
Based on 30O’s technical indicators, 30O is a Buy.
    What is 30O’s RSI (14)?
    30O’s RSI (14) is 68.77, which suggests 30O is a Neutral.
      What is 30O’s MACD?
      30O’s MACD is <0.01, which suggests 30O is a Sell.
        What is 30O’s 5-day moving average?
        30O’s 5-day moving average is 0.10, which suggests 30O is a Buy.
          What is 30O’s 20-day moving average?
          30O 20-day moving average is 0.09, which suggests 30O is a Buy.
            What is 30O’s 50-day moving average?
            30O’s 50-day moving average is 0.09, which suggests 30O is a Buy.
              What is 30O’s 200-day moving average?
              30O’s 200-day moving average is 0.12, which suggests 30O is a Sell.
                What is 30O’s Williams % R (14)?
                30O’s Williams % R (14) is -51.79, which suggests 30O is a Buy.
                  What is 30O’s CCI (14)?
                  30O’s CCI (14) is 197.00, which suggests 30O is a Sell.
                    What is the share price of OncoTherapy Science, Inc.?